There is a shifting paradigm towards shorter durations of antibiotics in pediatric infections. Conflicting international guidelines recommend treatment of urinary tract infection (UTI) with antibiotic courses ranging from just 3 days to 7–14 days. Antimicrobial resistance is a global health crisis, underscoring the importance of antibiotic stewardship. Investigators in the SCOUT Trial examine the impact of short-course (5 day) antibiotic therapy in UTI, with potentially far reaching implications.

https://rebelem.com/pediatric-utis-short-course-vs-standard-course-antibiotics-is-it-time-for-a-change/

Community-acquired pneumonia (CAP) can lead to pulmonary and systemic inflammation, resulting in impaired gas exchange, sepsis, organ failure, and an increased risk of death. Corticosteroids have excellent anti-inflammatory and immunomodulatory effects that could mitigate some of the inflammation caused by pneumonia. There have been several randomized trials that have shown glucocorticoids have positive effects in patients with CAP. However, except for one trial, none showed a between-group difference regarding mortality. We now have the Community-Acquired Pneumonia: Evaluation of Corticosteroids (CAPE COD) Trial.

https://rebelem.com/corticosteroids-in-severe-community-acquired-pneumonia-could-cape-cod-catalyze-a-change-in-critical-care-management/

Should we give oral ibuprofen or intramuscular ketorolac in the ED in patients who can take PO?

This week we discuss some of the serious infectious processes of pregnancy.

This week we discuss the diagnosis and management of Achilles tendon ruptures.

This week we once again borrow audio from the Only in Staten Podcast and feature a discussion on cardiogenic shock with the director of the CCU at SIUH, Dr. Martin Amor.

We've got toxicologist Dr. Sanjay Mohan back on to chat about carbon monoxide toxicity in the ED.

This week, Swami sits down with director of the Staten Island University Hospital cardiac catheterization lab, Dr. Ruben Kandov, to discuss ACS management.